These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

811 related articles for article (PubMed ID: 19443175)

  • 21. Recurrent ovarian carcinoma of low malignant potential: the role of secondary surgical cytoreduction and the prognosis in Chinese patients.
    Zang RY; Yang WT; Shi DR; Xing Y; Cai SM
    J Surg Oncol; 2005 Jul; 91(1):67-72. PubMed ID: 15999350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
    J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?
    Zang RY; Li ZT; Tang J; Cheng X; Cai SM; Zhang ZY; Teng NN
    Cancer; 2004 Mar; 100(6):1152-61. PubMed ID: 15022281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical evaluation of secondary cytoreduction in recurrent ovarian cancer.
    Munkarah AR; Coleman RL
    Gynecol Oncol; 2004 Nov; 95(2):273-80. PubMed ID: 15491746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of treatment and prognosis of recurrent epithelial ovarian carcinoma].
    Yuan GW; Wu LY; Yao HW; Hou JL; Li XG; Liu LY
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):710-3. PubMed ID: 20021871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged disease-free survival by maintenance chemotherapy among patients with recurrent platinum-sensitive ovarian cancer.
    Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Blumenson LE
    Gynecol Oncol; 1998 Nov; 71(2):190-5. PubMed ID: 9826459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer.
    Benedetti Panici P; De Vivo A; Bellati F; Manci N; Perniola G; Basile S; Muzii L; Angioli R
    Ann Surg Oncol; 2007 Mar; 14(3):1136-42. PubMed ID: 17195909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
    Scarabelli C; Gallo A; Carbone A
    Gynecol Oncol; 2001 Dec; 83(3):504-12. PubMed ID: 11733963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cytoreductive surgery in the management of stage IV epithelial ovarian cancer].
    Zang R; Zhang Z; Chen J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):197-9. PubMed ID: 11776157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Secondary cytoreductions in the treatment of ovarian cancers].
    Zylberberg B; Dormont D; Janklewicz S; Daraï E; Madelenat P; Antoine JM
    Gynecol Obstet Fertil; 2000 Feb; 28(2):127-36. PubMed ID: 10758587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of cytoreductive surgery for colon cancer metastatic to the ovary.
    McCormick CC; Giuntoli RL; Gardner GJ; Schulick RD; Judson K; Ronnett BM; Vang R; Bristow RE
    Gynecol Oncol; 2007 Jun; 105(3):791-5. PubMed ID: 17408727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma.
    Bristow RE; Duska LR; Montz FJ
    Gynecol Oncol; 2001 Apr; 81(1):92-9. PubMed ID: 11277657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of secondary cytoreductive surgery for recurrent ovarian cancer.
    Güngör M; Ortaç F; Arvas M; Kösebay D; Sönmezer M; Köse K
    Gynecol Oncol; 2005 Apr; 97(1):74-9. PubMed ID: 15790440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage cytoreductive surgery for recurrent endometrial cancer.
    Bristow RE; Santillan A; Zahurak ML; Gardner GJ; Giuntoli RL; Armstrong DK
    Gynecol Oncol; 2006 Oct; 103(1):281-7. PubMed ID: 16631236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients.
    Obermair A; Sevelda P
    Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study.
    Gadducci A; Cosio S; Zola P; Sostegni B; Ferrero AM; Teti G; Cristofani R; Sartori E
    Gynecol Oncol; 2010 Mar; 116(3):358-63. PubMed ID: 19954826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary cytoreductive surgery in the management of platinum-sensitive recurrent epithelial ovarian cancer.
    Park JY; Eom JM; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    J Surg Oncol; 2010 Apr; 101(5):418-24. PubMed ID: 20082350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome.
    Karam AK; Santillan A; Bristow RE; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Li AJ
    Gynecol Oncol; 2007 Feb; 104(2):377-80. PubMed ID: 17014899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.